Adherence to Therapy in Patients with Multiple Sclerosis-Review.
Aleksandra KołtuniukJustyna Chojdak-LukasiewiczPublished in: International journal of environmental research and public health (2022)
Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system (CNS). MS is an incurable disease. The goal of disease-modifying therapies (DMT) is to slow the progression of the disease, prevent relapses and increase the patient's overall quality of life. According to the World Health Organisation definition, adherence means the extent to which a person's medication-taking behaviour corresponds with the agreed upon treatment recommendations from a healthcare provider. Accurate adherence is necessary for efficient treatment. Non-adherence is related to unsuccessful treatments, the risk of relapses and increased healthcare costs. The aim of this study is to present the main factors relating to non-adherence in MS patients.
Keyphrases
- multiple sclerosis
- healthcare
- mass spectrometry
- ms ms
- primary care
- public health
- ejection fraction
- mental health
- emergency department
- white matter
- high resolution
- stem cells
- case report
- prognostic factors
- climate change
- metabolic syndrome
- blood brain barrier
- mesenchymal stem cells
- adipose tissue
- skeletal muscle
- weight loss
- health insurance
- social media
- patient reported
- human health
- patient reported outcomes